Cardiac/cardiovascular drug NOS, overdose/toxicity: Difference between revisions
Ttenbergen (talk | contribs) m Text replacement - "InitialEditorAssigned = Trish Ostryzniuk" to "InitialEditorAssigned = " |
|||
| Line 12: | Line 12: | ||
== Additional Info == | == Additional Info == | ||
Excludes | '''Includes''' | ||
* ACE inhibitor | |||
* ARBs | |||
* digoxin | |||
* other antihypertensives | |||
* lipid drugs | |||
'''Excludes''' | |||
*[[Beta-blocker, overdose/toxicity]] | *[[Beta-blocker, overdose/toxicity]] | ||
*[[Calcium channel blocker, overdose/toxicity]] | *[[Calcium channel blocker, overdose/toxicity]] | ||
*[[Cardiac/cardiovascular drug NOS, adverse effect]] | *[[Cardiac/cardiovascular drug NOS, adverse effect]] | ||
{{ICD10 Guideline overdose}} | {{ICD10 Guideline overdose}} | ||